Two coronavirus vaccine candidates developed by China's Clover Biopharmaceuticals triggered strong immune responses in an early-stage human trial and appeared to be safe, the company said on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback